TCRX
Price
$1.03
Change
+$0.12 (+13.19%)
Updated
Feb 6 closing price
Capitalization
57.15M
30 days until earnings call
Intraday BUY SELL Signals
VTGN
Price
$0.56
Change
+$0.06 (+12.00%)
Updated
Feb 6 closing price
Capitalization
22.24M
Intraday BUY SELL Signals
Interact to see
Advertisement

TCRX vs VTGN

Header iconTCRX vs VTGN Comparison
Open Charts TCRX vs VTGNBanner chart's image
TScan Therapeutics
Price$1.03
Change+$0.12 (+13.19%)
Volume$1.08M
Capitalization57.15M
VistaGen Therapeutics
Price$0.56
Change+$0.06 (+12.00%)
Volume$1.74M
Capitalization22.24M
TCRX vs VTGN Comparison Chart in %
TCRX
Daily Signal:
Gain/Loss:
VTGN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
TCRX vs. VTGN commentary
Feb 09, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TCRX is a Hold and VTGN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 09, 2026
Stock price -- (TCRX: $1.03 vs. VTGN: $0.56)
Brand notoriety: TCRX and VTGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: TCRX: 179% vs. VTGN: 51%
Market capitalization -- TCRX: $57.15M vs. VTGN: $22.24M
TCRX [@Biotechnology] is valued at $57.15M. VTGN’s [@Biotechnology] market capitalization is $22.24M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.26B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TCRX’s FA Score shows that 1 FA rating(s) are green whileVTGN’s FA Score has 1 green FA rating(s).

  • TCRX’s FA Score: 1 green, 4 red.
  • VTGN’s FA Score: 1 green, 4 red.
According to our system of comparison, both TCRX and VTGN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TCRX’s TA Score shows that 5 TA indicator(s) are bullish while VTGN’s TA Score has 5 bullish TA indicator(s).

  • TCRX’s TA Score: 5 bullish, 5 bearish.
  • VTGN’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, VTGN is a better buy in the short-term than TCRX.

Price Growth

TCRX (@Biotechnology) experienced а +0.98% price change this week, while VTGN (@Biotechnology) price change was +0.90% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.30%. For the same industry, the average monthly price growth was -2.98%, and the average quarterly price growth was +31.79%.

Reported Earning Dates

TCRX is expected to report earnings on Mar 11, 2026.

Industries' Descriptions

@Biotechnology (-2.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TCRX($57.1M) has a higher market cap than VTGN($22.2M). TCRX YTD gains are higher at: 3.000 vs. VTGN (-14.912). VTGN has higher annual earnings (EBITDA): -64.79M vs. TCRX (-136.89M). TCRX has more cash in the bank: 184M vs. VTGN (77.2M). VTGN has less debt than TCRX: VTGN (1.87M) vs TCRX (95.6M). TCRX has higher revenues than VTGN: TCRX (8.42M) vs VTGN (721K).
TCRXVTGNTCRX / VTGN
Capitalization57.1M22.2M257%
EBITDA-136.89M-64.79M211%
Gain YTD3.000-14.912-20%
P/E RatioN/AN/A-
Revenue8.42M721K1,168%
Total Cash184M77.2M238%
Total Debt95.6M1.87M5,126%
FUNDAMENTALS RATINGS
VTGN: Fundamental Ratings
VTGN
OUTLOOK RATING
1..100
83
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
97
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
TCRXVTGN
RSI
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
88%
Momentum
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
87%
Bullish Trend 4 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
88%
Advances
ODDS (%)
Bullish Trend 19 days ago
82%
Bullish Trend 8 days ago
80%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
89%
Bullish Trend 4 days ago
88%
Aroon
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
TCRX
Daily Signal:
Gain/Loss:
VTGN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OFSTF0.620.01
+2.24%
Carbon Streaming Corporation
GENSY42.140.28
+0.67%
Genus Plc
KGTFY16.70N/A
N/A
Krung Thai Bank Public Co., Ltd.
SRBIF3.55N/A
N/A
Serabi Gold Plc
EBRGF15.55N/A
N/A
Enbridge Inc.

TCRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TCRX has been closely correlated with VTGN. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if TCRX jumps, then VTGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TCRX
1D Price
Change %
TCRX100%
+13.14%
VTGN - TCRX
70%
Closely correlated
+11.52%
RZLT - TCRX
70%
Closely correlated
+6.85%
ARTV - TCRX
69%
Closely correlated
+4.13%
ARCT - TCRX
69%
Closely correlated
+7.83%
TPST - TCRX
67%
Closely correlated
+7.62%
More

VTGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTGN has been closely correlated with ARTV. These tickers have moved in lockstep 96% of the time. This A.I.-generated data suggests there is a high statistical probability that if VTGN jumps, then ARTV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTGN
1D Price
Change %
VTGN100%
+11.52%
ARTV - VTGN
96%
Closely correlated
+4.13%
QNCX - VTGN
92%
Closely correlated
-4.79%
CALC - VTGN
88%
Closely correlated
-1.77%
TPST - VTGN
87%
Closely correlated
+7.62%
RZLT - VTGN
86%
Closely correlated
+6.85%
More